| Louis J. Ignarro | |
|---|---|
| Born | May 31, 1941 |
| Nationality | American |
| Fields | pharmacology |
| Institutions | Tulane University School of Medicine, UCLA School of Medicine, King Saud University |
| Known for | nitric oxide |
| Notable awards | Nobel Prize in Physiology or Medicine (1998) |
Louis J. Ignarro (born May 31, 1941) is an American pharmacologist. He was corecipient of the 1998 Nobel Prize in Physiology or Medicine with Robert F. Furchgott and Ferid Murad for demonstrating the signaling properties of nitric oxide.
He is currently professor of pharmacology at the UCLA School of Medicine's department of molecular and medical pharmacology in Los Angeles, which he joined in 1985. Before relocating to California, he was a professor of pharmacology at Tulane University School of Medicine, New Orleans, for 12 years. Ignarro has also previously worked as a staff scientist, research department, for the pharmaceutical division of CIBA-GEIGY Corporation in New York.
Ignarro has published numerous articles on his research. He received the Basic Research Prize of the American Heart Association in 1998, in recognition of his outstanding contributions to the advancement of cardiovascular science. That same year, he was inducted into the National Academy of Sciences and the following year, into the American Academy of Arts and Sciences.
He is the founder of the Nitric Oxide Society, and founder and editor-in-chief of Nitric Oxide Biology and Chemistry.[1] Ignarro holds a B.S. in pharmacy, Columbia University, 1962, and a Ph.D. in pharmacology, University of Minnesota, School of Medicine, 1966. He also received a postdoctoral fellowship in chemical pharmacology from National Institutes of Health in 1968. He is a member of the scientific committee of Nicox, a French pharmaceutical company, a member of the Board of Directors of Antibe Therapeutics,[2] a Canadian drug discovery company, a member of the Board of Directors of Operation USA, a non-profit organization, and a member of the Nutritional Advisory Board for Herbalife, a for-profit nutrition and weight-management company.
Contents |
Born of Italian immigrants, Ignarro grew up near New York City, and had a predilection for science from an early age, which led to a bachelor's degree in pharmacy from Columbia University and a Ph.D. in pharmacology from the University of Minnesota. His university studies also concentrated in chemistry, enzymology and cardiovascular physiology, and resulted in several published papers. His work continued at the NIH in the fields he'd studied, collaborating with many other scientists to discover regulatory mechanisms of the cardiovascular system that would lead to his most famous work.
Ignarro worked with Herbalife to develop Niteworks, a dietary supplement designed to boost the body’s own production of nitric oxide, and later became a member of the company’s Scientific Advisory Board. Ignarro endorsed this product in exchange for a royalty agreement reported to have earned his consulting firm over $1 million in the first 12 months.
Ignarro also promoted Niteworks' ingredients in the Proceedings of the National Academy of Sciences, where, as a member of the National Academy of Sciences, he can submit papers without review, and furthermore without disclosing his financial interest to the publication. After Ignarro's ties to Herbalife were revealed, the journal issued a correction to the article, citing Ignarro's undisclosed "conflict of interest." UCLA conducted its own investigation and determined that Ignarro did not act improperly as all the research was done in Italy and no research funds came from UCLA. Therefore, it was not legally necessary for him to disclose anything. Ignarro presents a one-hour Herbalife promotional video for Niteworks.